CAPTRUST Financial Advisors
FOLD

CAPTRUST Financial Advisors’s Amicus Therapeutics FOLD Stock Holding History

CAPTRUST Financial Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$222K Sell
15,335
-10,065
-40% -$144K ﹤0.01% 2613
2025
Q4 		$362K Buy
25,400
+460
+2% +$4.52K ﹤0.01% 2110
2025
Q3 		$197K Buy
+24,940
New +$177K ﹤0.01% 2435
2022
Q3 		– Sell
-248
Closed -$3K – 2771
2022
Q2 		$3K Sell
248
-538
-68% -$4.43K ﹤0.01% 4293
2022
Q1 		$7K Buy
786
+577
+276% +$5.41K ﹤0.01% 3959
2021
Q4 		$2K Hold
209
– – ﹤0.01% 4403
2021
Q3 		$2K Buy
209
+30
+17% +$307 ﹤0.01% 4252
2021
Q2 		$2K Sell
179
-110
-38% -$1.07K ﹤0.01% 4164
2021
Q1 		$3K Buy
+289
New +$4.47K ﹤0.01% 3910

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

CAPTRUST Financial Advisors's FOLD Position: Q1 2026 in Review

CAPTRUST Financial Advisors reduced its Amicus Therapeutics (FOLD) stake by 40% in Q1 2026, selling an estimated $144K and leaving 15,335 shares worth $222K. The position accounts for ﹤0.01% of the portfolio, ranked #2613.

CAPTRUST Financial Advisors first reported a position in FOLD in Q1 2021 and has held it in 9 quarters since. The position peaked at $362K in Q4 2025. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • CAPTRUST Financial Advisors held 15,335 shares of Amicus Therapeutics worth $222K as of Q1 2026.
  • CAPTRUST Financial Advisors sold 10,065 Amicus Therapeutics shares in Q1 2026, an estimated $144K.
  • Amicus Therapeutics made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #2613 holding.
  • CAPTRUST Financial Advisors first reported a position in Amicus Therapeutics in Q1 2021 and has held it in 9 quarters since.
  • CAPTRUST Financial Advisors's Amicus Therapeutics position peaked at $362K in Q4 2025.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.